Full Truck Alliance, Lufax, Atour Lifestyle among premarket losers' pack

Dec. 12, 2022 8:33 AM ETACET, NOTV, NRBO, MMAT, TOUR, AFMD, SLI, ENSC, ALLO, DOYU, BXRX, LU, PHVS, YMM, AMAM, ATATBy: Meghavi Singh, SA News Editor

Adicet Bio (ACET) -36% ahead of updated Phase 1 data for blood cancer therapy.
Ambrx Biopharma (AMAM) -25%.
Affimed (AFMD) -24% after citing lack of durability, Affimed scraps AFM13 monotherapy plans for NK cell combo.
Inotiv (NOTV) -21% after delays the release of its financial results for the Q4 and FY ended September 30, 2022.
Baudax Bio (BXRX) -17%.
NeuroBo Pharmaceuticals (NRBO) -10%.
Meta Materials (MMAT) -10%.
Tuniu (TOUR) -9%.
Ensysce Biosciences (ENSC) -8%.
Full Truck Alliance (YMM) -7%.
DouYu International (DOYU) -7%.
Allogene Therapeutics (ALLO) -7%.
Atour Lifestyle (ATAT) -6%.
Pharvaris (PHVS) -5%.
Standard Lithium (SLI) -5%.
Lufax (LU) -5%.